We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$167M
Cap. Flow
+$24.1M
Cap. Flow %
1.76%
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$19.7M
2
PDD icon
Pinduoduo
PDD
+$16.1M
3
NIO icon
NIO
NIO
+$12.8M
4
MRVL icon
Marvell Technology
MRVL
+$11M
5
TSM icon
TSMC
TSM
+$10.1M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$23.6M
2
LEGN icon
Legend Biotech
LEGN
+$19.4M
3
TCOM icon
Trip.com Group
TCOM
+$15.4M
4
ZLAB icon
Zai Lab
ZLAB
+$8.54M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.1%
2 Technology 29.22%
3 Communication Services 14%
4 Healthcare 8.72%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBD icon
176
Warner Bros
WBD
$64.6B
$389K 0.03%
25,759
-1,694
-6% -$24.1K
MDGL icon
177
Madrigal Pharmaceuticals
MDGL
$12.6B
$387K 0.03%
1,599
-3,933
-71% -$1.07M
WMT icon
178
Walmart Inc
WMT
$871B
$385K 0.03%
7,839
-384
-5% -$18.2K
PCVX icon
179
Vaxcyte
PCVX
$7.89B
$383K 0.03%
10,212
+279
+3% +$11.8K
HZNP
180
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$383K 0.03%
3,510
-836
-19% -$92.4K
CYTK icon
181
Cytokinetics
CYTK
$11B
$382K 0.03%
10,848
-958
-8% -$39.1K
MCD icon
182
McDonald's
MCD
$188B
$382K 0.03%
1,365
-50
-4% -$13.4K
IOVA icon
183
Iovance Biotherapeutics
IOVA
$2.23B
$380K 0.03%
62,188
+1,236
+2% +$8.53K
CPRT icon
184
Copart
CPRT
$25.9B
$379K 0.03%
10,088
-658
-6% -$22.4K
UTHR icon
185
United Therapeutics
UTHR
$26.3B
$378K 0.03%
1,689
+181
+12% +$44.6K
ALGN icon
186
Align Technology
ALGN
$12B
$377K 0.03%
1,128
-325
-22% -$95.9K
BMY icon
187
Bristol-Myers Squibb
BMY
$127B
$376K 0.03%
5,424
-41
-0.8% -$2.89K
WDAY icon
188
Workday
WDAY
$33.4B
$375K 0.03%
1,817
-102
-5% -$18.6K
FOLD
189
DELISTED
Amicus Therapeutics
FOLD
$374K 0.03%
33,758
-2,403
-7% -$29.6K
ARWR icon
190
Arrowhead Research
ARWR
$12.1B
$373K 0.03%
14,679
+701
+5% +$22K
AZN icon
191
AstraZeneca
AZN
$263B
$373K 0.03%
2,685
-217
-7% -$29.2K
BAC icon
192
Bank of America
BAC
$435B
$372K 0.03%
13,001
-512
-4% -$16.9K
IRWD icon
193
Ironwood Pharmaceuticals
IRWD
$611M
$372K 0.03%
35,319
-366
-1% -$4.1K
SRPT icon
194
Sarepta Therapeutics
SRPT
$1.66B
$370K 0.03%
2,684
-889
-25% -$115K
TWST icon
195
Twist Bioscience
TWST
$5.62B
$369K 0.03%
24,474
+7,243
+42% +$160K
BEAM icon
196
Beam Therapeutics
BEAM
$2.58B
$368K 0.03%
12,016
+1,981
+20% +$78.2K
VCYT icon
197
Veracyte
VCYT
$4.52B
$368K 0.03%
16,507
+1,740
+12% +$42.1K
INSM icon
198
Insmed
INSM
$23.2B
$366K 0.03%
21,479
-1,418
-6% -$27.6K
MRTX
199
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$366K 0.03%
9,847
-208
-2% -$9.36K
RXDX
200
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$362K 0.03%
3,377
-459
-12% -$52.8K
6 7
8
9 10

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, E Fund Management held 359 positions worth $1.37B, up 14% from $1.2B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q1 2023 filing shows 25 new, 120 increased, 185 reduced and 27 closed positions. Its largest new stake was Alibaba: 31,628 shares worth $3.23M. The largest sale was Qualcomm, an estimated $23.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q1 2023 buy was Alibaba: 31,628 shares worth $3.23M.
  • E Fund Management added most to Microsoft in Q1 2023, an estimated $19.7M increase.
  • E Fund Management's biggest Q1 2023 reduction was Qualcomm, cutting an estimated $23.6M.
  • E Fund Management fully exited United States Brent Oil Fund in Q1 2023, selling an estimated $1.75M.
  • E Fund Management's ten largest holdings make up 57% of its $1.37B portfolio in Q1 2023.
  • E Fund Management opened 25 new positions and closed 27 in Q1 2023.
  • E Fund Management's portfolio value rose 14% quarter-over-quarter to $1.37B.

Based on E Fund Management's 13F filing for Q1 2023, filed 11 May 2023.